SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-23-000048
Filing Date
2023-05-09
Accepted
2023-05-09 16:15:23
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20230331.htm   iXBRL 10-Q 1268618
2 EX-31.1 exel20230331exhibit31110q.htm EX-31.1 9574
3 EX-31.2 exel20230331exhibit31210q.htm EX-31.2 9546
4 EX-32.1 exel20230331exhibit32110q.htm EX-32.1 7303
10 exel-20230331_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-23-000048.txt   6214050

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20230331.xsd EX-101.SCH 44726
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20230331_cal.xml EX-101.CAL 67680
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20230331_def.xml EX-101.DEF 192961
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20230331_lab.xml EX-101.LAB 475087
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20230331_pre.xml EX-101.PRE 325074
65 EXTRACTED XBRL INSTANCE DOCUMENT exel-20230331_htm.xml XML 1072894
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

IRS No.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 23902196
SIC: 2836 Biological Products, (No Diagnostic Substances)